focus
Previous article:
In age of alternative facts, a scholarly course on calling out crap
Next article: JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology
Next article: JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology
hotspot
hotspot
-
Readout LOUD podcast: live from JPM 2024
2025-09-29 22:36 -
Doudna institute plans to 'cure hundreds of diseases' with CRISPR
2025-09-29 21:33 -
Biotech reporter’s notebook: A sunnier mood at JPM 2024
2025-09-29 21:31 -
Intermittent fasting comes with a heart risk? Not so fast
2025-09-29 21:18 -
Caregivers of transplant patients call for more support, training
2025-09-29 21:17 -
Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex
2025-09-29 20:42